Figure 1.

Diagnoses of the 40 serous tubal intraepithelial carcinomas identified from 10 523 cases in the Calgary Laboratory Services database from 2014 to 2016. Numbers and percentage of cases that were diagnosed with cancer, and the proportion of cases within the various histotypes of cancer that were diagnosed with STIC. *Other organ sites: vaginal (squamous), breast (ductal), cervix (squamous, adenocarcinoma, glandular), pelvic wall (leiomyosarcoma), small intestine (mixed), renal (clear cell), peritoneum (serous), liver (cholangiocarcinoma), colon (adenocarcinoma, adenoneuroendocrine, mucinous, signet-ring cell carcinoma, squamous), bladder (urothelial carcinoma), and appendix (adenocarcinoma, goblet cell carcinoid, mucinous, neuroendocrine). †Ovarian cancer (other): low-grade serous, endometrioid, clear cell, mucinous and non-epithelial cancers (carcinosarcoma, germ cell, granulosa, melanoma, mixed, sex cord, teratocarcinosarcoma). ‡Tubal cancer (other): MMMT, carcinosarcoma.§Endometrial cancer (other): endometrioid, mucinous, clear cell, MMMT, carcinosarcoma, choriocarcinoma, mixed, neuroendocrine, undifferentiated.